Ran Pan
Impact in
-
- Diet, Metabolism, and Disease
- Natural Antidiabetic Agents Studies
Papers in
-
- Adipokines, Inflammation, and Metabolic Diseases 2
- Liver Disease Diagnosis and Treatment 2
-
- Peroxisome Proliferator-Activated Receptors 2
- RNA Interference and Gene Delivery 1
- Chromatin Remodeling and Cancer 1
- Biochemical and Molecular Research 1
- Co-authors
- Zhuo‐Xian Meng (5 shared papers)Lei Ding (1 shared paper)Linfeng Hu (1 shared paper)Fuli Zhang (1 shared paper)Yongliang Xia (1 shared paper)Bin Ying Ding (1 shared paper)Linwensi Zhu (1 shared paper)Xiaobing Dou (1 shared paper)
- Journals
- International Journal of Nanomedicine (1 paper)Protein & Cell (1 paper)Biopharmaceutics & Drug Disposition (1 paper)International Immunopharmacology (1 paper)Liver International (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ran Pan
10 papers receiving 308 citations
Peers
Comparison fields: 5 of 58
- Endocrinology, Diabetes and Metabolism 50
- Biochemistry 17
- Pharmacology 24
- Epidemiology 82
- Hepatology 15
Countries citing papers authored by Ran Pan
This map shows the geographic impact of Ran Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Pan more than expected).
Fields of papers citing papers by Ran Pan
This network shows the impact of papers produced by Ran Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Pan. The network helps show where Ran Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 123 | |
| 2 | 2017 | 45 | |
| 3 | 2022 | 41 | |
| 4 | 2022 | 36 | |
| 5 | 2021 | 20 | |
| 6 | 2022 | 19 | |
| 7 | 2023 | 8 | |
| 8 | 2024 | 7 | |
| 9 | 2025 | 6 | |
| 10 | 2020 | 5 | |
| 11 | 1999 | 1 | |
| 12 | 2026 | 0 |
About Ran Pan
Ran Pan is a scholar working on Epidemiology, Molecular Biology, Hepatology, Pharmacology and Water Science and Technology, having authored 12 papers that have together received 311 indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Liver Disease Diagnosis and Treatment (2 papers), RNA Interference and Gene Delivery (1 paper), Pancreatic function and diabetes (1 paper), Diabetes and associated disorders (1 paper), Chromatin Remodeling and Cancer (1 paper) and Biochemical and Molecular Research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (50 citations), Biochemistry (17 citations), Pharmacology (24 citations), Epidemiology (82 citations) and Hepatology (15 citations). Ran Pan has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zhuo‐Xian Meng, Lei Ding, Linfeng Hu, Fuli Zhang, Yongliang Xia, Bin Ying Ding, Linwensi Zhu, Xiaobing Dou, Wenjing Zhang and Jiandie D. Lin. Their work appears in journals such as International Journal of Nanomedicine, Protein & Cell, Biopharmaceutics & Drug Disposition, International Immunopharmacology and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.